Table 4 Patients’ biological profile at day 7 in the three treatment groups
Parameters | DHAPQ (N = 176) | AL (N = 178) | ASAQ (N = 180) | p value |
|---|---|---|---|---|
Hb mean (g/dl) | 10.74 | 10.75 | 10.96 | 0.19 |
Anemia (Hb < 11 g/dl) (%) | 63.64 | 70.79 | 69.44 | 0.31 |
ALAT (UI/L, mean ± SD) | 16.42 | 17.34 | 18.19 | 0.58 |
ASAT (UI/L, mean ± SD) | 25.6 | 23.9 | 25.8 | 0.09 |
Patients with ALAT < 40 UI/L (%) | 90.34 | 93.82 | 91.67 | 0.47 |
Patients with ASAT < 40 UI/L (%) | 90.91 | 95.51 | 98.89 | 0.002 |
Mean bilirubin (mg/dl) | 0.56 | 0.58 | 0.64 | 0.02 |
Patients with normal level of bilirubin (0.23 – 1 mg/dl) (%) | 96.59 | 96.07 | 93.89 | 0.42 |
Mean creatinine (mg/l) | 7.74 | 7.31 | 7.72 | 0.93 |
Patients with normal level of creatinine (6 – 14 mg/l) (%) | 96.59 | 96.07 | 100 | 0.03 |